These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 38001323)

  • 21. TOTAL BODY ADIPOSITY, TRIGLYCERIDES, AND LEG FAT ARE INDEPENDENT RISK FACTORS FOR DIABETIC PERIPHERAL NEUROPATHY IN CHINESE PATIENTS WITH TYPE 2 DIABETES MELLITUS.
    Zhen Q; Yao N; Chen X; Zhang X; Wang Z; Ge Q
    Endocr Pract; 2019 Mar; 25(3):270-278. PubMed ID: 30913011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of kiwifruit on metabolic health in patients with cardiovascular risk factors: a systematic review and meta-analysis.
    Suksomboon N; Poolsup N; Lin W
    Diabetes Metab Syndr Obes; 2019; 12():171-180. PubMed ID: 30774402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of probiotics at different intervention time on glycemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
    Wang X; Chen L; Zhang C; Shi Q; Zhu L; Zhao S; Luo Z; Long Y
    Front Endocrinol (Lausanne); 2024; 15():1392306. PubMed ID: 39114293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of lifestyle interventions on cardiovascular risk factors among adults without impaired glucose tolerance or diabetes: A systematic review and meta-analysis.
    Zhang X; Devlin HM; Smith B; Imperatore G; Thomas W; Lobelo F; Ali MK; Norris K; Gruss S; Bardenheier B; Cho P; Garcia de Quevedo I; Mudaliar U; Jones CD; Durthaler JM; Saaddine J; Geiss LS; Gregg EW
    PLoS One; 2017; 12(5):e0176436. PubMed ID: 28493887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial.
    Derosa G; Cicero AF; D'Angelo A; Fogari E; Salvadeo S; Gravina A; Ferrari I; Fassi R; Fogari R
    Clin Ther; 2007 Apr; 29(4):602-10. PubMed ID: 17617283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fecal microbiota transplantation for irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Wang M; Xie X; Zhao S; Ma X; Wang Z; Zhang Y
    Front Immunol; 2023; 14():1136343. PubMed ID: 37275867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treating Type 2 Diabetes Mellitus Patients Complicated with Metabolic Syndrome by Benefiting Qi Dissolving Method].
    Wang TZ; Huo QP; Fu XD; He YM; Wang WJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Sep; 36(9):1065-1071. PubMed ID: 30645844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fecal microbiota transplantation improves metabolic syndrome parameters: systematic review with meta-analysis based on randomized clinical trials.
    Proença IM; Allegretti JR; Bernardo WM; de Moura DTH; Ponte Neto AM; Matsubayashi CO; Flor MM; Kotinda APST; de Moura EGH
    Nutr Res; 2020 Nov; 83():1-14. PubMed ID: 32987284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of traditional Chinese medicine on gut microbiota in adults with type 2 diabetes: A systematic review and meta-analysis.
    Zheng Y; Ding Q; Wei Y; Gou X; Tian J; Li M; Tong X
    Phytomedicine; 2021 Jul; 88():153455. PubMed ID: 33478831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intensity Differences of Resistance Training for Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis.
    Fan T; Lin MH; Kim K
    Healthcare (Basel); 2023 Feb; 11(3):. PubMed ID: 36767015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between gut microbiota and susceptibility to type 2 diabetes mellitus in rats.
    An Y; Dai H; Duan Y; Cheng L; Shi L; He C; Wang C; Lv Y; Li H; Zhang H; Huang Y; Fu W; Sun W; Zhao B
    Chin Med; 2023 May; 18(1):49. PubMed ID: 37147692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short- and Long-Term Effects of Wholegrain Oat Intake on Weight Management and Glucolipid Metabolism in Overweight Type-2 Diabetics: A Randomized Control Trial.
    Li X; Cai X; Ma X; Jing L; Gu J; Bao L; Li J; Xu M; Zhang Z; Li Y
    Nutrients; 2016 Sep; 8(9):. PubMed ID: 27618090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy and safety of dachaihu decoction in the treatment of type 2 diabetes mellitus: A systematic review and meta-analysis.
    Zhang Z; Leng Y; Fu X; Yang C; Xie H; Yuan H; Liang Q; Gao H; Xie C
    Front Pharmacol; 2022; 13():918681. PubMed ID: 36003504
    [No Abstract]   [Full Text] [Related]  

  • 34. Promising Treatment for Type 2 Diabetes: Fecal Microbiota Transplantation Reverses Insulin Resistance and Impaired Islets.
    Wang H; Lu Y; Yan Y; Tian S; Zheng D; Leng D; Wang C; Jiao J; Wang Z; Bai Y
    Front Cell Infect Microbiol; 2019; 9():455. PubMed ID: 32010641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta cell functionality and hepatic insulin resistance are major contributors to type 2 diabetes remission and starting pharmacological therapy: from CORDIOPREV randomized controlled trial.
    Roncero-Ramos I; Gutierrez-Mariscal FM; Gomez-Delgado F; Villasanta-Gonzalez A; Torres-Peña JD; Cruz-Ares S; Rangel-Zuñiga OA; Luque RM; Ordovas JM; Delgado-Lista J; Perez-Martinez P; Camargo A; Alcalá-Diaz JF; Lopez-Miranda J
    Transl Res; 2021 Dec; 238():12-24. PubMed ID: 34298148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of fish oil supplementation on glucose control and lipid levels among patients with type 2 diabetes mellitus: a Meta-analysis of randomized controlled trials.
    Gao C; Liu Y; Gan Y; Bao W; Peng X; Xing Q; Gao H; Lai J; Liu L; Wang Z; Yang Y
    Lipids Health Dis; 2020 May; 19(1):87. PubMed ID: 32384902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A preliminary study on the effects of fecal microbiota transplantation on the intestinal microecology of patients with severe pneumonia during the convalescence period].
    Zhong P; Xu Y; Ye S; Yang F; Wu L; Su G; Liu Y; Feng J; Wang Y; Wu Z; Zheng Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Apr; 35(4):352-357. PubMed ID: 37308187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of pomegranate (Punica granatum) supplementation on metabolic status in patients with type 2 diabetes: A systematic review and meta-analysis.
    Jandari S; Hatami E; Ziaei R; Ghavami A; Yamchi AM
    Complement Ther Med; 2020 Aug; 52():102478. PubMed ID: 32951728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Washed microbiota transplantation improves patients with metabolic syndrome in South China.
    Wu L; Lu XJ; Lin DJ; Chen WJ; Xue XY; Liu T; Xu JT; Xie YT; Li MQ; Lin WY; Zhang Q; Wu QP; He XX
    Front Cell Infect Microbiol; 2022; 12():1044957. PubMed ID: 36457852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sumac fruit supplementation improve glycemic parameters in patients with metabolic syndrome and related disorders: A systematic review and meta-analysis.
    Ghafouri A; Estêvão MD; Alibakhshi P; Pizarro AB; Kashani AF; Persad E; Heydari H; Hasani M; Heshmati J; Morvaridzadeh M
    Phytomedicine; 2021 Sep; 90():153661. PubMed ID: 34334274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.